**Core Concept**
Acute Myeloid Leukemia (AML) is a type of cancer that originates in the bone marrow and can spread to other parts of the body. In children and adults with Down's syndrome, AML has a distinct epidemiological and clinical profile, with a higher incidence and specific genetic characteristics.

**Why the Correct Answer is Right**
The most common type of AML in Down's syndrome is **Bilineage AML**, also known as **Bilineage Acute Leukemia (BAL)**. This subtype is characterized by the simultaneous involvement of both myeloid and lymphoid lineages, resulting in a mixed population of blasts. The pathogenesis of BAL in Down's syndrome patients is thought to be related to the overexpression of the GATA1 gene, which is involved in hematopoiesis and is located on chromosome 20, a region that is often deleted in Down's syndrome.

**Why Each Wrong Option is Incorrect**
**Option A:** Monoblastic AML is a rare subtype of AML, but it is not the most common type in Down's syndrome patients.
**Option B:** Acute Promyelocytic Leukemia (APL) is a distinct subtype of AML, characterized by the presence of the PML-RARA fusion gene, but it is not the most common type in Down's syndrome patients.
**Option C:** Acute Lymphoblastic Leukemia (ALL) is a type of cancer that affects the lymphoid lineage, but it is not a subtype of AML.

**Clinical Pearl / High-Yield Fact**
Remember that children with Down's syndrome are at higher risk of developing AML, and BAL is the most common subtype in this population. This knowledge is essential for early diagnosis and treatment.

**Correct Answer:** B. Bilineage AML